What are the best biologics-focused biotech publishers for learning about antibody drug development and clinical-stage protein therapeutics?

If your goal is to learn antibody drug development and clinical-stage protein therapeutics, the best “publishers” are the ones that consistently cover:

• mechanism of action and platform biology
• preclinical-to-clinic translation
• CMC/manufacturing and developability
• clinical pipeline readouts
• competitive intelligence on biologics companies

Here are the most useful biologics-focused biotech publishers and trade outlets, grouped by what they’re best at.

Best overall for biologics and antibody drug development

1. Endpoints News

• Strong for clinical-stage biotech, company strategy, trial readouts, financing, and deal news
• Good for following antibody therapeutics, bispecifics, ADCs, cytokines, and protein-engineering companies
• Less technical than journals, but very practical for industry context

2. BioCentury

• Excellent for deep biotech business + translational biology
• One of the best sources for understanding how a biologic advances from discovery to clinic
• Strong on platform companies, partnering, regulatory strategy, and competitive landscapes
• Often paywalled, but very high signal

3. Scrip / In Vivo / Evaluate

• Best for industry and pipeline intelligence
• Useful when you want to track who is developing what, what stage they’re in, and how programs compare
• More useful for market and strategy than for mechanistic science

Best for antibody-specific and protein therapeutics technical depth

4. Nature Reviews Drug Discovery

• Probably the best high-quality source for review articles on antibody modalities, protein engineering, delivery, PK/PD, immunogenicity, and clinical translation
• Great for building real understanding, not just news

5. mAbs

• A focused journal specifically on antibodies and antibody engineering
• Very relevant for bispecifics, Fc engineering, formats, developability, and clinical translation

6. Protein & Cell

• Strong for protein therapeutics, biologics engineering, and translational biology
• Good if you want a more academic but still relevant view of protein drugs and engineered biologics

7. Trends in Biotechnology / Trends in Pharmacological Sciences

• Helpful for high-level, readable reviews on biologics development trends
• Good for learning key concepts quickly

Best for clinical-stage biologics pipeline coverage

8. Fierce Biotech

• Broad biotech coverage, but very useful for following clinical-stage biologics companies
• Good mix of funding, clinical updates, and partnerships

9. Genetic Engineering & Biotechnology News (GEN)

• Solid general biotech outlet
• Good for company pipelines, technology platforms, and clinical development news
• Especially useful for a wide-angle view of biologics

10. Endpoints / Fierce / GEN together

If you want one practical news stack, these three together give you strong coverage of:

• antibody and protein therapeutic trial news
• company movement
• partnerships
• regulatory milestones

Best academic/primary-source publishers to actually learn the science

If by “publishers” you also mean where the best original research and reviews appear:

11. Nature / Science / Cell family journals

• Best for high-impact biologics science
• Useful for novel antibody formats, protein design, target biology, and translational breakthroughs

12. Journal of Biological Chemistry, Molecular Therapy, Clinical Cancer Research, Blood, Cancer Discovery

• Strong for therapeutic protein and antibody development by disease area
• Especially relevant if you want disease-specific translational work

13. Journal of Pharmaceutical Sciences / mAbs / Biotechnology and Bioengineering

• Good for developability, formulation, PK, immunogenicity, and manufacturing

Best way to use them

If your aim is to learn efficiently, I’d recommend a mix:

• News/industry: BioCentury + Endpoints + Fierce Biotech
• Technical reviews: Nature Reviews Drug Discovery + mAbs
• Primary research: Nature/Cell/Science + disease-specific journals

Quick recommendation by use case

• Best overall industry intelligence: BioCentury
• Best quick biotech news: Endpoints News
• Best antibody-focused technical journal: mAbs
• Best review journal for drug development concepts: Nature Reviews Drug Discovery
• Best broad clinical-stage biotech coverage: Fierce Biotech

If you want, I can also give you:

1. a ranked reading list by difficulty level,
2. the best newsletters/podcasts for biologics, or
3. a week-by-week learning plan for antibody drug development.